- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01997242
The Surgery After Stenting (SAS) Registry (SAS registry)
June 23, 2025 updated by: Azienda USL Reggio Emilia - IRCCS
A Multicenter Registry of Consecutive Patients Undergoing Cardiac and Noncardiac Surgery or Operative Endoscopic/Endovascular Procedures After Implantation of a Coronary Stent
The SAS registry will include any patient with previous coronary stenting undergoing any type of surgery or operative endoscopic/endovascular procedure at the participating Centers.
The relevant clinical, procedural and outcome data (within index surgical admission and at 30 days) will be entered in a specifically designed electronic case record form (eCRF).
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Reggio Emilia, Italy, 42123
- Arcispedale Santa Maria Nuova- IRCCS
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients with prior coronary stenting undergoing urgent or elective surgical/endoscopic procedures
Description
Inclusion Criteria:
- Eligible will be male and female patients > 18 years of age.
- Eligible will be patients with previous coronary stenting undergoing any kind of surgical or operative endoscopic procedure at the participating Centers, irrespective of the distance in time between stenting and surgery.
- Both candidates to elective/urgent operations and those undergoing emergency operations will be included in the SAS registry, and will be considered as two separate cohorts.
Exclusion Criteria:
- Unwillingess/inability to sign the Informed Consent Form (ICF). There are no other selection criteria.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
stenting undergoing surgery
Patients with prior coronary stenting undergoing urgent or elective surgical/endoscopic procedures
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The composite of death, myocardial infarction, probable/definite stent thrombosis according the Academic Research Consortium definition and bleeding events of Bleeding Academic Research Consortium (BARC)grade >3 during index surgical admission.
Time Frame: within the first 30 days after surgery
|
within the first 30 days after surgery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The incidence of bleeding events of Bleeding Academic Research Consortium (BARC) grade >3 within 30 days of index admission/procedure
Time Frame: within the first 30 days after surgery
|
within the first 30 days after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Study Chair: Roberta Rossini, MD, Cardiovascular Dpt, Ospedali Riuniti di Bergamo
- Study Chair: Stefano Savonitto, MD, Division of Cardiology, Manzoni Hospital, Lecco
- Study Chair: Giovanni Tortorella, MD, Arcispedale Santa Maria Nuova - IRCCS, Reggio Emilia
- Principal Investigator: Marco Ferri, MD, Arcispedale Santa Maria Nuova - IRCCS, Reggio Emilia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 10, 2013
Primary Completion (Actual)
December 31, 2014
Study Completion (Actual)
December 31, 2014
Study Registration Dates
First Submitted
September 14, 2013
First Submitted That Met QC Criteria
November 27, 2013
First Posted (Estimated)
November 28, 2013
Study Record Updates
Last Update Posted (Actual)
June 26, 2025
Last Update Submitted That Met QC Criteria
June 23, 2025
Last Verified
June 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- ASMN-18/2013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PERCUTANEOUS CORONARY INTERVENTION
-
Ospedale della MisericordiaUnknownTo Achieve an Early Reendothelialization at the Expense of Low Restenosis: The EREMUS Study (EREMUS)Percutaneous Coronary Intervention | Angioplasty, Transluminal, Percutaneous CoronaryItaly
-
Ospedale Sandro Pertini, RomaCompletedPercutaneous Coronary Intervention | Coronary AngiographyItaly
-
Shenzhen Institute of Advanced Biomedical Robot...Not yet recruitingPercutaneous Coronary InterventionChina
-
Shenyang Northern HospitalCompletedPercutaneous Coronary InterventionChina
-
Beijing Anzhen HospitalPeking UniversityUnknownPercutaneous Coronary Intervention
-
Assiut UniversityUnknownPercutaneous Coronary Intervention
-
ZhangWenduoUnknownPercutaneous Coronary InterventionChina
-
Wake Forest University Health SciencesCompleted
-
Duke UniversityAcist Medical SystemsCompletedPercutaneous Coronary InterventionUnited States
-
China National Center for Cardiovascular DiseasesUnknownPercutaneous Coronary InterventionChina